Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Mar 31, 2026, 4:00 PM EDT
1.280
0.00 (0.00%)
After-hours: Mar 31, 2026, 4:00 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $114.12 million as of March 31, 2026. Its market cap has decreased by -33.25% in one year.
Market Cap
114.12M
Enterprise Value
100.58M
1-Year Change
-33.25%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has decreased from $125.22M to $114.12M, a decrease of -8.86%. That is a compound annual growth rate of -0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 115.51M | -33.38% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 127.56M |
| Artiva Biotherapeutics | 123.83M |
| Kalaris Therapeutics | 123.58M |
| Karyopharm Therapeutics | 123.54M |
| Sangamo Therapeutics | 119.27M |
| Equillium | 118.87M |
| Black Diamond Therapeutics | 116.30M |
| Inovio Pharmaceuticals | 111.24M |